Animalcare’s FY25 trading update sees the company delivering in-line with expectations, with strong revenue and underlying EBITDA growth (+20% and +50% respectively) reflecting positive progress across the core business and the beneficial impact of the Randlab acquisition. As we outlined in our recent initiation of coverage (‘A Breed Apart’, 13 January 2025), Animalcare has effected an evolution in its operational footprint over the past decade and in our view today’s update demonstrates that th ....
